KR20230154219A - 세로토닌성 작용제와 관련된 장애의 치료에 유용한 세로토닌성 작용제로서의 인돌 유도체 - Google Patents

세로토닌성 작용제와 관련된 장애의 치료에 유용한 세로토닌성 작용제로서의 인돌 유도체 Download PDF

Info

Publication number
KR20230154219A
KR20230154219A KR1020237033351A KR20237033351A KR20230154219A KR 20230154219 A KR20230154219 A KR 20230154219A KR 1020237033351 A KR1020237033351 A KR 1020237033351A KR 20237033351 A KR20237033351 A KR 20237033351A KR 20230154219 A KR20230154219 A KR 20230154219A
Authority
KR
South Korea
Prior art keywords
deuterium
compounds
hydrogen
disorder
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237033351A
Other languages
English (en)
Korean (ko)
Inventor
압델말릭 슬라시
요셉 아라우조
가이 앤드류 히긴스
Original Assignee
마인드셋 파마 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마인드셋 파마 인크. filed Critical 마인드셋 파마 인크.
Publication of KR20230154219A publication Critical patent/KR20230154219A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020237033351A 2021-03-02 2022-03-02 세로토닌성 작용제와 관련된 장애의 치료에 유용한 세로토닌성 작용제로서의 인돌 유도체 Pending KR20230154219A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163155634P 2021-03-02 2021-03-02
US63/155,634 2021-03-02
PCT/CA2022/050295 WO2022183287A1 (en) 2021-03-02 2022-03-02 Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Publications (1)

Publication Number Publication Date
KR20230154219A true KR20230154219A (ko) 2023-11-07

Family

ID=83153685

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020237033351A Pending KR20230154219A (ko) 2021-03-02 2022-03-02 세로토닌성 작용제와 관련된 장애의 치료에 유용한 세로토닌성 작용제로서의 인돌 유도체
KR1020237033368A Pending KR20230154220A (ko) 2021-03-02 2022-03-02 세로토닌성 작용제와 관련된 장애의 치료에 유용한 세로토닌성 작용제로서의 인돌 유도체

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020237033368A Pending KR20230154220A (ko) 2021-03-02 2022-03-02 세로토닌성 작용제와 관련된 장애의 치료에 유용한 세로토닌성 작용제로서의 인돌 유도체

Country Status (11)

Country Link
US (2) US20240166599A1 (cg-RX-API-DMAC7.html)
EP (2) EP4301730A4 (cg-RX-API-DMAC7.html)
JP (2) JP7894380B2 (cg-RX-API-DMAC7.html)
KR (2) KR20230154219A (cg-RX-API-DMAC7.html)
CN (2) CN117500788A (cg-RX-API-DMAC7.html)
AU (2) AU2022229695A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023017754A2 (cg-RX-API-DMAC7.html)
CA (2) CA3210270A1 (cg-RX-API-DMAC7.html)
IL (2) IL305481A (cg-RX-API-DMAC7.html)
MX (2) MX2023010317A (cg-RX-API-DMAC7.html)
WO (2) WO2022183287A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use
MX2024008691A (es) * 2022-01-14 2024-07-19 Cybin Irl Ltd Composiciones y metodos de triptamina.
CA3265884A1 (en) * 2022-08-31 2024-03-07 Cybin Irl Limited TRYPTAMINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
US12396981B2 (en) 2023-03-09 2025-08-26 William Shulman Methods of using DMT
TW202519206A (zh) * 2023-11-06 2025-05-16 大陸商宜昌人福藥業有限責任公司 一種n,n-二甲基色胺衍生物及其藥物組合物、製備方法和用途
WO2025104490A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
WO2025104491A1 (en) * 2023-11-14 2025-05-22 Mindset Pharma Inc. Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
ES2566056T3 (es) * 2001-03-29 2016-04-08 Eli Lilly And Company N-(2-ariletil)bencilaminas como antagonistas del receptor 5-HT6
TWI318621B (en) * 2006-08-03 2009-12-21 Nat Bureau Of Controlled Drugs Dept Of Health A series of deuterium labelled compounds as drug testing standards and their preparations
US20090062367A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched eletriptan
DK2753605T3 (da) * 2011-09-09 2019-06-17 Lantheus Medical Imaging Inc Sammensætninger, fremgangsmåder, og systemer til syntesen og anvendelsen af billeddannelsesmidler
WO2018094106A2 (en) * 2016-11-16 2018-05-24 University Of South Florida ALLOSTERIC ANTAGONISTS OF GPRC6a AND THEIR USE IN MITIGATING PROTEINOPATHIES
US12616706B2 (en) * 2019-03-07 2026-05-05 Arbormentis LLC Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations
GB201907871D0 (en) * 2019-06-03 2019-07-17 Small Pharma Ltd Therapeutic compositions
MX2022009527A (es) * 2020-02-04 2022-11-16 Mindset Pharma Inc Derivados de la psilocina como agentes psicodelicos serotoninergicos para el tratamiento de trastornos del snc.
AU2021215709A1 (en) * 2020-02-04 2022-09-01 Mindset Pharma Inc. 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
WO2021218896A1 (zh) * 2020-04-26 2021-11-04 江苏恒瑞医药股份有限公司 海鞘素类衍生物及其制备方法与医药用途
IL312785B2 (en) * 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use

Also Published As

Publication number Publication date
EP4301747A4 (en) 2025-01-22
IL305622A (en) 2023-11-01
BR112023017754A2 (pt) 2023-11-21
EP4301730A1 (en) 2024-01-10
AU2022229695A1 (en) 2023-09-28
EP4301730A4 (en) 2025-01-22
JP2024508545A (ja) 2024-02-27
CA3210270A1 (en) 2022-09-09
CN117242065A (zh) 2023-12-15
JP2024508922A (ja) 2024-02-28
CN117500788A (zh) 2024-02-02
CA3210275A1 (en) 2022-09-09
EP4301747A1 (en) 2024-01-10
MX2023010317A (es) 2023-11-09
AU2022229037A1 (en) 2023-09-28
JP7894380B2 (ja) 2026-07-23
US20240166599A1 (en) 2024-05-23
WO2022183287A1 (en) 2022-09-09
KR20230154220A (ko) 2023-11-07
WO2022183288A1 (en) 2022-09-09
MX2023010316A (es) 2023-11-09
US20240166630A1 (en) 2024-05-23
IL305481A (en) 2023-10-01

Similar Documents

Publication Publication Date Title
US11427604B2 (en) Psilocin derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
JP7824222B2 (ja) 中枢神経系障害の治療のためのセロトニン作動性幻覚薬としての3-ピロリジンインドール誘導体
US20240166599A1 (en) Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
JP2023553094A (ja) 中枢神経系障害の治療のためのセロトニン作動性薬としての3位環-アミンインドール誘導体
AU2022328466A1 (en) 3-cycloamino-indole compounds as serotonergic agents useful for the treatment of disorders related thereto
HK40106138A (en) Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
HK40105243A (en) Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto
BR122024002267A2 (pt) Derivados de psilocina como agentes psicodélicos serotonérgicos para o tratamento de distúrbios do snc
HK40084439A (en) Psilocin derivatives as serotonergic psychedelic agents for the treatment of cns disorders

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000